Similar Posts
Exploring Compatibility Between Lipid-Based Formulations and Shell Materials
To ensure the physical and chemical stability of Lipid-Based Formulations (LBFs), it is essential to find a delicate balance between the formulation…
Survey Reveals Orphan Drugs Companies are Hindered by Internal Limitations
Orphan drugs encounter challenges that extend from their initial discovery to eventual launch, primarily due to the restricted patient numbers and niche…
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Enhanced Softgel Coatings for Consumer Products
Coated softgels such as enteric, delayed release and fixed dose combinations are an ideal solution for protecting the active ingredients from the…
What is Formulation Development? Why is it so important in making medicines?
When making medicines, figuring out how to turn a new drug into something people can take is a really big deal. This…
Translating Lab Discoveries: Preclinical to First-in-Human Development.
Overview Drug developers have to take into account several factors to position a pre-clinical drug candidate successfully for first-in-human clinical trials. This executive summary will outline…
